{"entities":{"Q6997534":{"pageid":21488193,"ns":120,"title":"Item:Q6997534","lastrevid":83665745,"modified":"2026-05-07T09:53:12Z","type":"item","id":"Q6997534","labels":{"en":{"language":"en","value":"BOP2: Bayesian optimal design for phase II clinical trials with simple and complex endpoints"}},"descriptions":{"en":{"language":"en","value":"scientific article; zbMATH DE number 8026961"}},"aliases":{},"claims":{"P31":[{"mainsnak":{"snaktype":"value","property":"P31","hash":"fd5912e4dab4b881a8eb0eb27e7893fef55176ad","datavalue":{"value":{"entity-type":"item","numeric-id":56887,"id":"Q56887"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6997534$18F6F7D7-E7CB-4295-A254-DC518E1DE7E1","rank":"normal"}],"P159":[{"mainsnak":{"snaktype":"value","property":"P159","hash":"abf2ba3d219364d621ee6f1c47c607e6e1d6c69d","datavalue":{"value":{"text":"BOP2: Bayesian optimal design for phase II clinical trials with simple and complex endpoints","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q6997534$747A7F9C-A9AB-4363-B709-915D0D863A3C","rank":"normal"}],"P225":[{"mainsnak":{"snaktype":"value","property":"P225","hash":"379514be680bab052f19e1e7d5510dd4ca16a178","datavalue":{"value":"1559.62302","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q6997534$AB367DD2-0229-4153-B966-2ED1FE047E3F","rank":"normal"}],"P27":[{"mainsnak":{"snaktype":"value","property":"P27","hash":"31f26ea43df0be9ae523b3e226b2d940678a1eff","datavalue":{"value":"10.1002/SIM.7338","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q6997534$D3543F81-FCCA-442C-BC82-EC4416F15644","rank":"normal"}],"P16":[{"mainsnak":{"snaktype":"value","property":"P16","hash":"220e5d71576be4df91d242100d32f0525f82de55","datavalue":{"value":{"entity-type":"item","numeric-id":177219,"id":"Q177219"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6997534$6D5240E0-BFE7-4E9F-82D4-B008A331436E","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P16","hash":"2f89a05d7cdfaa1575cf4efb844bb937c17e45c4","datavalue":{"value":{"entity-type":"item","numeric-id":6878034,"id":"Q6878034"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6997534$8B5F66F6-1E5F-47A9-9A8E-08B65119C3A8","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P16","hash":"7e7f53b3acd9c202ded6fd94dc7f33476720cf59","datavalue":{"value":{"entity-type":"item","numeric-id":1034391,"id":"Q1034391"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6997534$F19B0403-E321-48B9-9000-67E72D71FA4E","rank":"normal"}],"P200":[{"mainsnak":{"snaktype":"value","property":"P200","hash":"f176889fea30d36256fbae63fbc48f1ea28cd207","datavalue":{"value":{"entity-type":"item","numeric-id":57552,"id":"Q57552"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6997534$582C8D39-50E0-4672-A99E-3FDDC36AAD1B","rank":"normal"}],"P28":[{"mainsnak":{"snaktype":"value","property":"P28","hash":"245a9974d2522220f2c65fb0c1b34bab596c746d","datavalue":{"value":{"time":"+2025-04-14T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q6997534$EDB95ECA-4FA2-4E43-AE7A-D76EABA280FD","rank":"normal"}],"P226":[{"mainsnak":{"snaktype":"value","property":"P226","hash":"708a6f1a75f978962215fcdf6748c16c77f4fd6e","datavalue":{"value":"62P10","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q6997534$CB969AA5-7EA2-4BB2-9D01-D56690F7D73C","rank":"normal"}],"P1451":[{"mainsnak":{"snaktype":"value","property":"P1451","hash":"02cc8d7fabc40bf2a0745d94b267b75a3a15b37e","datavalue":{"value":"8026961","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q6997534$762A1BF1-841D-4950-8926-1350E7030CBB","rank":"normal"}],"P1450":[{"mainsnak":{"snaktype":"value","property":"P1450","hash":"d71316dae9aec51b2fcf22e40138b6eee448bbac","datavalue":{"value":"Bayesian adaptive design","type":"string"},"datatype":"string"},"type":"statement","id":"Q6997534$AE4BC8E5-DBD4-41F6-843F-C81BB59807ED","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P1450","hash":"f30d5c47ad7e723c8bad061446554406302b33c2","datavalue":{"value":"early stopping","type":"string"},"datatype":"string"},"type":"statement","id":"Q6997534$A6567C20-2EB9-49BC-806D-F904A35EE3FF","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P1450","hash":"e4a6c5f9452d27001eef2de9b32988dbf810734b","datavalue":{"value":"ordinal endpoint","type":"string"},"datatype":"string"},"type":"statement","id":"Q6997534$B8C37F61-8174-49C2-8A0C-373C1B7DCF8C","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P1450","hash":"0973cf748882d2c613f5889d3454e5c02f4fb923","datavalue":{"value":"co-primary endpoints","type":"string"},"datatype":"string"},"type":"statement","id":"Q6997534$B039A52F-4D8E-43BA-8EF2-107E2975B3E7","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P1450","hash":"2d052b455c9d567980e3be3c4750367462be7d38","datavalue":{"value":"immunotherapy","type":"string"},"datatype":"string"},"type":"statement","id":"Q6997534$95AB23AB-D7CD-4D02-BB6D-01AD5DB16786","rank":"normal"}],"P1460":[{"mainsnak":{"snaktype":"value","property":"P1460","hash":"57f7fea50d2ce1b39b695c4a1313582eed405e38","datavalue":{"value":{"entity-type":"item","numeric-id":5976449,"id":"Q5976449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6997534$E2BE54DB-9B0A-4BE6-8022-EEA7207AF3CC","rank":"normal"}],"P223":[{"mainsnak":{"snaktype":"value","property":"P223","hash":"c028de97a500ad53105262fbaf7790c3dc283670","datavalue":{"value":{"entity-type":"item","numeric-id":3938400,"id":"Q3938400"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6997534$C8D41872-6919-4621-A8D9-B0510AE8CADD","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P223","hash":"7cb312d9f9b7a2b552b77bbbe8312df19a37a25a","datavalue":{"value":{"entity-type":"item","numeric-id":4842831,"id":"Q4842831"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6997534$BC12E0F4-11E9-4F06-93AD-FB42CBC14E3D","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P223","hash":"fa000cb29295c7175409cb27ba87ba180dd36553","datavalue":{"value":{"entity-type":"item","numeric-id":6907032,"id":"Q6907032"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6997534$3E094E18-BFDD-44C0-9393-819026322977","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P223","hash":"2e379741fab07992c15499d549787a90a2dd7ac6","datavalue":{"value":{"entity-type":"item","numeric-id":4642533,"id":"Q4642533"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6997534$9780308B-1583-4E2A-A751-37E5AC5E4BB3","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P223","hash":"9229b2a711add80b9012b1d3ced57776463bc766","datavalue":{"value":{"entity-type":"item","numeric-id":4020592,"id":"Q4020592"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6997534$1B78AF77-1D09-4D80-B176-72675FF8A054","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P223","hash":"1a23c7aa7bae5ab1d22462cf11c41dc5eff6e5e6","datavalue":{"value":{"entity-type":"item","numeric-id":4274354,"id":"Q4274354"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q6997534$D9E342FD-3780-4C00-88B8-B7D589774DC0","rank":"normal"}]},"sitelinks":{"mardi":{"site":"mardi","title":"BOP2: Bayesian optimal design for phase II clinical trials with simple and complex endpoints","badges":[],"url":"https://portal.mardi4nfdi.de/wiki/BOP2:_Bayesian_optimal_design_for_phase_II_clinical_trials_with_simple_and_complex_endpoints"}}}}}